For the Inventor, By the Inventor

Enter assignee name

Xspray Pharma Ab

USPTO Granted Patents = 18

EPO Patents = 5

Forward Citations = 18

Loading Chart...

Loading Chart...

10 inventors (with patents filed for the assignee):

Magnus Brisander (9 out of 23 patents)

Thomas Meijer (9 out of 12 patents)

Victor Söderberg (9 out of 10 patents)

4. Gérald Jesson (8 out of 20 patents)

5. Martin Malmsten (8 out of 20 patents)

6. Helene Dérand (8 out of 20 patents)

7. Mustafa Demirbüker (8 out of 22 patents)

8. Per X Andersson (8 out of 40 patents)

9. Andreas Fischer (1 out of 16 patents)

10. Thomas Andersson (1 out of 1 patent)

11. Mustafa DEMIRBÛKER (0 patent)

18 patents: Sort by Forward Citations

1. 12576071 - Pharmaceutical compositions (2026-03-17),

2. 12419892 - Pharmaceutical compositions comprising nilotinib (2025-09-23),

3. 12144804 - Pharmaceutical compositions (2024-11-19),

4. 12076314 - Pharmaceutical compositions (2024-09-03),

5. 11963951 - Pharmaceutical compositions (2024-04-23),

6. 11833249 - Rapidly disintegrating solid oral dosage forms containing dasatinib (2023-12-05),

7. 11529351 - Fast dissolving pharmaceutical compositions (2022-12-20),

8. 11517562 - Pharmaceutical compositions (2022-12-06),

9. 11426391 - Pharmaceutical compositions (2022-08-30),

10. 11376243 - Pharmaceutical compositions (2022-07-05),

11. 11344500 - Rapidly disintegrating solid oral dosage forms containing dasatinib (2022-05-31),

12. 11241419 - Pharmaceutical compositions (2022-02-08),

13. 10894018 - Rapidly disintegrating solid oral dosage forms containing dasatinib (2021-01-19),

14. 10894017 - Rapidly disintegrating solid oral dosage forms containing dasatinib (2021-01-19),

15. 10874614 - Rapidly disintegrating solid oral dosage forms containing dasatinib (2020-12-29),

Xspray Pharma AB is a pharmaceutical company based in Solna, Sweden, specializing in the development of innovative drug delivery systems. The company focuses on enhancing the bioavailability of existing drugs through its proprietary technology, which aims to improve therapeutic outcomes for patients. Xspray Pharma's research primarily targets oncology and other therapeutic areas, leveraging its expertise in formulation development to create more effective treatments. The organization is committed to advancing healthcare through its novel approaches in drug formulation.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

18 Patents

#13 in Solna

#365 in Sweden

#34,146 in the World

Xspray Pharma Ab

Forward Citations = 18

10 inventors:

Magnus Brisander (9 out of 23 patents)

Thomas Meijer (9 out of 12 patents)

Victor Söderberg (9 out of 10 patents)

4. Gérald Jesson (8 out of 20 patents)

5. Martin Malmsten (8 out of 20 patents)

Please report any incorrect information to [email protected]

Loading…